REFERENCES

References and Acknowledgements

I am very fortunate to have had lots of help and support during this project. Many thanks in particular to Dr Simon Milling, Professor Kevin O'Dell and Dr Pasquale Maffia from the School of Life Sciences at the University of Glasgow as well as Claire Daniel and all of the staff in the University of Glasgow Archives.

(2011). Recommendations for the Prevention of Perinatal Group B Streptococcal (GBS) Disease. PEDIATRICS 128, 611-616.

Abraham, E. (2003). Nuclear Factor–κB and Its Role in Sepsis‐Associated Organ Failure. The Journal Of Infectious Diseases 187, S364-S369.

Almansa, R., Wain, J., Tamayo, E., Andaluz-Ojeda, D., Martin-Loeches, I., Ramirez, P., and Bermejo-Martin, J. (2013). Immunological monitoring to prevent and treat sepsis. Critical Care 17, 109.

Cameron, R. (1960). Robert Muir. 1864-1959. Biographical Memoirs Of Fellows Of The Royal Society5, 149-173.

Chen, X., Yin, Y., and Zhang, J. (2011). Sepsis and immune response. World J Emerg Med 2, 88-92.

D'Elia, R., Harrison, K., Oyston, P., Lukaszweski, R., and Clark, G. (2013). Targeting the “Cytokine Storm” for Therapeutic Benefit. Clinical And Vaccine Immunology 20, 319-327.

Dias, M., Hegde, R., Pinto, H., and Bhat, P. (2013). Salmonella paratyphi B septicemia in a neonate. J Clin Neonatol 2, 93.

Efthymiou, C., and Weir, W. (2011). Salmonella sepsis simulating gastrointestinal ischaemia following cardiopulmonary bypass. Interactive Cardiovascular And Thoracic Surgery 12, 334-336.

Gaind, R., Mohanty, S., Sehgal, R., Chellani, H., and Deb, M. (2009). Neonatal sepsis due to Salmonella Typhi and Paratyphi A. J Infect Dev Ctries 3.

He, T., Hu, J., Yan, G., Li, L., Zhang, D., Zhang, Q., Chen, B., and Huang, Y. (2015). Pigment epithelium-derived factor regulates microvascular permeability through adipose triglyceride lipase in sepsis. Clin. Sci. 129, 49-61.

Hersch, M., Skorochod, I., Kanter, L., Gurevitz, M., and Goldstein, R. (2000). Increased intestinal permeability accompanies the development of sepsis in ICU patients. Critical Care 4, P140.

Hotchkiss, R., Monneret, G., and Payen, D. (2013). Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. The Lancet Infectious Diseases 13, 260-268.

Keynan, Y., and Rubinstein, E. (2013). Pathophysiology of Infective Endocarditis. Current Infectious Disease Reports 15, 342-346.

Lawrence, K., and Kollef, M. (2009). Antimicrobial Stewardship in the Intensive Care Unit. Am J Respir Crit Care Med 179, 434-438.

Liu, D. (2008). Handbook of Listeria monocytogenes (Boca Raton: Taylor & Francis).

Lowth, D. (2015). Typhoid and Paratyphoid Fever. Enteric fever information | Patient.

Mogasale, V., Maskery, B., Ochiai, R., Lee, J., Mogasale, V., Ramani, E., Kim, Y., Park, J., and Wierzba, T. (2014). Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. The Lancet Global Health 2, e570-e580.

Muir, R., and Ritchie, J. (1899). Manual of Bacteriology (Edinburgh and London: Young J. Pentland).

Muir, R. (1924). Text-book of Pathology (London: Edward Arnold & Co.).

Pathan, N. (2003). Pathophysiology of meningococcal meningitis and septicaemia. Archives Of Disease In Childhood 88, 601-607.

Pulickal, A., Gautam, S., Clutterbuck, E., Thorson, S., Basynat, B., Adhikari, N., Makepeace, K., Rijpkema, S., Borrow, R., and Farrar, J. et al. (2009). Kinetics of the Natural, Humoral Immune Response to Salmonella enterica Serovar Typhi in Kathmandu, Nepal. Clinical And Vaccine Immunology 16, 1413-1419.

Randhawa, V., Kumar, A., Saili, A., Datta, V., Agrawal, C., and Mehta, G. (2007). Paratyphoid sepsis. Indian J Pediatr 74, 197-198.

Rebielus, (1925). Muir's "Pathology". The British Medical Journal Reviews 787-788.

Reinhart, K., Bauer, M., Riedemann, N., and Hartog, C. (2012). New Approaches to Sepsis: Molecular Diagnostics and Biomarkers. Clinical Microbiology Reviews 25, 609-634.

Rittirsch, D., Flierl, M., and Ward, P. (2008). Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8, 776-787.

Root, R., Lodato, R., Patrick, W., Cade, J., Fotheringham, N., Milwee, S., Vincent, J., Torres, A., Rello, J., and Nelson, S. (2003). Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis*. Critical Care Medicine 31, 367-373.

Samant, S., Lee, H., Ghassemi, M., Chen, J., Cook, J., Mankin, A., and Neyfakh, A. (2008). Nucleotide Biosynthesis Is Critical for Growth of Bacteria in Human Blood. Plos Pathog 4, e37.

Steinberg, B., Goldenberg, N., and Lee, W. (2012). Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods. Antiviral Research 93, 2-15.

Thomas, L. (1972). Germs. New England Journal Of Medicine 287, 553-555.

van der Poll, T., and Opal, S. (2008). Host–pathogen interactions in sepsis. The Lancet Infectious Diseases 8, 32-43.

Velge, P., Wiedemann, A., Rosselin, M., Abed, N., Boumart, Z., Chaussé, A., Grépinet, O., Namdari, F., Roche, S., and Rossignol, A. et al. (2012). Multiplicity of Salmonella entry mechanisms, a new paradigm for Salmonella pathogenesis. Microbiologyopen 1, 243-258.

Waterer, G., and Rello, J. (2011). Why should we measure bacterial load when treating community-acquired pneumonia?. Current Opinion In Infectious Diseases 24, 137-141.

Wesche-Soldato, D., Swan, R., Chung, C., and Ayala, A. (2007). The Apoptotic Pathway as a Therapeutic Target in Sepsis. Current Drug Targets 8, 493-500.

Wiersinga, W., Leopold, S., Cranendonk, D., and van der Poll, T. (2013). Host innate immune responses to sepsis. Virulence 5, 36-44.

(MSD), M. (2015). Sepsis and Septic Shock - Critical Care Medicine.

(1959). Obituary: Sir Robert Muir. The British Medical Journal 1, 1050-1051